Table 1.

Patient demographics for the study AKI+ and AKI− populations

Patient DemographicsAKI− Population (n = 10)AKI+ Population (n = 10)
Patient characteristics
    age (average)28 to 70 (46.6)23 to 65 (45.5)
    gender60% Women60% Women
    race90% Caucasian90% Caucasian
10% African American10% African American
Comorbidities
    CKD00
    diabetes21
    hypertension33
    cardiovascular disease (CHF and CAD)12
    PVD00
    chronic liver disease02
Clinical data
    admission diagnosis (N)Sepsis (7)Sepsis + ATN (5)
Lymphoma + ATN (1)
Tumor lysis + ATN (1)
ATN (2)
ESLD, hypotension + ATN (1)
    AKIN stage (N)I (4)I (0)
    based on creatinine measured in research laboratory compared to baseline or admissionII (1)II (0)
III (0)III (10)
    APACHE II score (average)20 to 41 (29.8)20 to 45 (32.7)
    RRT requirement0%100%
    overall mortality0%30%
    sepsis70%70%
Laboratory data
    ICU admission creatinine (mg/dl) (average)0.5 to 1.0 (0.7)0.5 to 7.96 (3.0)
    sample creatinine as measured in research laboratory0.8 to 1.5 (1.0)1.2 to 8.3 (3.8)
    peak creatinine (average)0.57 to 1.23 (0.83)3.9 to 9.58 (6.3)
    baseline creatinine (average)0.5 to 0.96 (0.7)0.5 to1.1 (0.8)